MEDIWOUND LTD. Rightofuse Assets Revalued Assets At Cost
MEDIWOUND LTD. (MDWD) had Rightofuse Assets Revalued Assets At Cost of $8.70 million as of 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Notes
ifrs-full:RightofuseAssetsRevaluedAssetsAtCost · last filed 2026-03-05
- 2025-12-31: Rightofuse Assets Revalued Assets At Cost $8.70M.
- 2024-12-31: Rightofuse Assets Revalued Assets At Cost $7.64M.
- 2023-12-31: Rightofuse Assets Revalued Assets At Cost $7.16M.
- 2022-12-31: Rightofuse Assets Revalued Assets At Cost $2.89M.
| Period end | Rightofuse Assets Revalued Assets At Cost |
|---|---|
| 2025-12-31 | $8.70M 20-F · filed 2026-03-05 |
| 2024-12-31 | $7.64M 20-F · filed 2026-03-05 |
| 2023-12-31 | $7.16M 20-F · filed 2026-03-05 |
| 2022-12-31 | $2.89M 20-F · filed 2025-03-19 |
| 2021-12-31 | $2.92M 20-F · filed 2024-03-21 |
| 2020-12-31 | $2.74M 20-F · filed 2023-03-16 |
| 2019-12-31 | $2.80M 20-F · filed 2022-03-17 |
| 2018-12-31 | $46.00K 20-F · filed 2021-02-25 |